GB202213372D0 - Arginase 2 vaccine - Google Patents
Arginase 2 vaccineInfo
- Publication number
- GB202213372D0 GB202213372D0 GBGB2213372.2A GB202213372A GB202213372D0 GB 202213372 D0 GB202213372 D0 GB 202213372D0 GB 202213372 A GB202213372 A GB 202213372A GB 202213372 D0 GB202213372 D0 GB 202213372D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- arginase
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 102100030356 Arginase-2, mitochondrial Human genes 0.000 title 1
- 101000792835 Homo sapiens Arginase-2, mitochondrial Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2213372.2A GB202213372D0 (en) | 2022-09-13 | 2022-09-13 | Arginase 2 vaccine |
PCT/EP2023/054568 WO2023161346A1 (en) | 2022-02-24 | 2023-02-23 | Arginase 2 vaccine |
PCT/EP2023/054573 WO2023161350A1 (en) | 2022-02-24 | 2023-02-23 | Nucleotide delivery of cancer therapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2213372.2A GB202213372D0 (en) | 2022-09-13 | 2022-09-13 | Arginase 2 vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202213372D0 true GB202213372D0 (en) | 2022-10-26 |
Family
ID=83945167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2213372.2A Ceased GB202213372D0 (en) | 2022-02-24 | 2022-09-13 | Arginase 2 vaccine |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202213372D0 (en) |
-
2022
- 2022-09-13 GB GBGB2213372.2A patent/GB202213372D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2594365B (en) | Coronavirus vaccine | |
GB202004974D0 (en) | Coronavirus vaccine | |
GB202004493D0 (en) | Coronavirus vaccine | |
GB202002166D0 (en) | Vaccine | |
GB202212336D0 (en) | Coronavirus vaccine formulations | |
EP4135847A4 (en) | Coronavirus vaccine | |
IL283133A (en) | Immunogenic arginase 2 polypeptides | |
GB202217951D0 (en) | Coronavirus vaccine | |
EP4213872A4 (en) | Piv5-based covid-19 vaccine | |
IL306088A (en) | Coronavirus vaccine formulations | |
GB202213372D0 (en) | Arginase 2 vaccine | |
GB202202547D0 (en) | Arginase 2 vaccine | |
SG11202108896UA (en) | Vaccine adjuvants and formulations | |
GB202318238D0 (en) | Vaccine | |
GB202301244D0 (en) | Vaccine | |
GB202218142D0 (en) | Vaccine | |
GB202218115D0 (en) | Vaccine | |
GB202218002D0 (en) | Vaccine | |
GB202200963D0 (en) | Vaccine | |
GB202313354D0 (en) | Poxvirus vaccine | |
IL304441A (en) | Measles-hiv or measles-htlv vaccine | |
GB202317903D0 (en) | Vaccine formulation | |
GB201901803D0 (en) | Medical patent 3189 | |
GB201901804D0 (en) | Medical patent 41989 | |
GB202318081D0 (en) | Cornavirus vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |